Detalhe da pesquisa
1.
IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.
Proc Natl Acad Sci U S A
; 119(31): e2201376119, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35878022
2.
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis.
Mol Cancer
; 23(1): 6, 2024 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184565
3.
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Mol Cancer
; 22(1): 110, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443114
4.
Drugging the PI3K/AKT/mTOR Pathway in ER+ Breast Cancer.
Int J Mol Sci
; 24(5)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36901954
5.
Signaling pathways essential for triple-negative breast cancer stem-like cells.
Stem Cells
; 39(2): 133-143, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211379
6.
Aurora Kinase A and Bcl-xL Inhibition Suppresses Metastasis in Triple-Negative Breast Cancer.
Int J Mol Sci
; 23(17)2022 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077449
7.
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer.
Breast Cancer Res
; 23(1): 26, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602273
8.
DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma.
Mol Cancer
; 20(1): 108, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446021
9.
Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins.
Nucleic Acids Res
; 47(13): 6668-6684, 2019 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31114908
10.
ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy.
Acta Oncol
; 59(1): 40-47, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31478407
11.
CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
Int J Cancer
; 144(3): 631-640, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30110125
12.
De novo pathway-based biomarker identification.
Nucleic Acids Res
; 45(16): e151, 2017 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934488
13.
SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Breast Cancer Res
; 20(1): 60, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29921289
14.
Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening.
Stem Cells
; 35(8): 1898-1912, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600813
15.
One-step FPLC-size-exclusion chromatography procedure for purification of rDMBT1 6 kb with increased biological activity.
Anal Biochem
; 542: 16-19, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169777
16.
KeyPathwayMinerWeb: online multi-omics network enrichment.
Nucleic Acids Res
; 44(W1): W98-W104, 2016 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27150809
17.
NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.
Mol Cell Proteomics
; 14(11): 2988-99, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26351264
18.
The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
BMC Genomics
; 17: 442, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27277198
19.
Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
Acta Oncol
; 55(2): 167-77, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26057535
20.
S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype.
Int J Cancer
; 137(9): 2093-103, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25912829